Search results (853)
« Back to NewsBody-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
Christos Kotanidis wins ESC Young Investigator Award 2025 in Preventive Cardiology
8 September 2025
Congratulations to Dr Christos Kotanidis, NIHR-funded Academic Clinical Lecturer in Cardiology, who has been awarded the 2025 ESC Young Investigator Award in Preventive Cardiology at the European Society of Cardiology Congress in Madrid.
Weight loss alone doesn’t ease atrial fibrillation symptoms in older adults, study finds
29 August 2025
A clinical trial led by researchers in the University of Oxford’s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm symptoms or reduce the need for further treatment.
DPhil sponsorship agreement with medical university and hospital /medical centre in Taiwan
29 August 2025
On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.
‘Targeted Therapies’ at Big Bang Fair 2025
20 August 2025
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
Scientists reveal how new diabetes and obesity drugs work
19 August 2025
A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.
Platelets Shown to Store DNA in Study that could Transform Cancer Screening
15 August 2025
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
RDM DM student awarded prestigious Ramsay Scholarship
7 August 2025
RDM Doctor of Medicine (DM) student Nicholas Clarke is one of 28 exceptional young people awarded the 2025 Ramsay Postgraduate Scholarship.
Wellcome Discovery Award for Claus Nerlov
31 July 2025
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.
New study links cancer stage to strength of antitumoral immune response in HR+ breast cancer
29 July 2025
The latest study from researchers in the MRC Translational Immune Discovery Unit in the MRC Weatherall Institute of Molecular Medicine has been published in Cell Reports Medicine.
Immune cells show promise in treating hypertrophic cardiomyopathy
21 July 2025
A new study from scientists at the Radcliffe Department of Medicine and Harvard Medical School, and funded by the British Heart Foundation, has uncovered a potential new treatment for hypertrophic cardiomyopathy (HCM).
£1.3m MRC Partnership Grant to expand the use of innovative Hyperpolarised Magnetic Resonance Imaging
15 July 2025
The technology has the potential to revolutionise the detection and monitoring of disease
Making it Personal – Engaging the public through theatre
14 July 2025
Innovative public engagement project explores the intersection of cutting-edge science and the raw honesty of the stage.
Thelior Bio: rethinking gut health from the inside out
10 July 2025
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
New tool allows researchers to track how mutations arise in tissues
3 July 2025
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC Weatherall Institute of Molecular Medicine (WIMM) community gathered for its flagship annual event, WIMM Day, on Tuesday 24 June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
Sten Eirik W. Jacobsen retires from the Bass Professorship
26 June 2025
On 30 June Professor Sten Eirik W. Jacobsen is retiring after 19 years as the Bass Professor of Developmental and Stem Cell Biology at the University of Oxford. His work has unravelled novel insights into normal and malignant haematopoietic stem and progenitor cell biology.
RDM announces a further three Principal Investigators for 2025
26 June 2025
We are delighted to announce the designation of three new Principal Investigators (PIs).
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
RDM researchers have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Congratulations to our new Associate Professors
5 June 2025
RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers.